Transcript: Abbott Laboratories (ABT) Q3 2026 Earnings Call
Abbott Laboratories (NYSE: ABT) reported third quarter 2026 sales growth of 7% and earnings per share growth of 9%, with adjusted EPS of $1.42, and announced plans to separate its… Read More »Transcript: Abbott Laboratories (ABT) Q3 2026 Earnings Call



